View
13
Download
0
Category
Preview:
Citation preview
PRE-FEASIBILITY REPORT
of
Intermediates & Bulk Drugs manufacturing unit
By
M/s. Vadivarhe Speciality Chemicals Ltd.
At
Gut No. – 204, Nashik – Mumbai highway, A/p – Vadivarhe,
Tal. – Igatpuri, Dist. – Nashik – 422 403
Maharashtra
1
INDEX
Sr. no. Description Page no.
1.0 Executive Summery 2
2.0 Introduction of project 3
2.1 Project proponent 3
2.2 Brief description of nature of the project 3
2.3 Need for the project & its important to the country and or
region
3
2.4 Demand supply Gap 4
2.5 Employment generation (Direct & Indirect) due to the project 5
3.0 Project description 5
3.1 Products & product capacity 7
3.2 Raw material requirement 10
3.3 Manufacturing process 10
3.4 Resource-utilize & recycling 11
3.4.1 Water Requirement 11
3.4.2 Power requirement 12
3.4.3 Fuel requirement 12
3.5 Quantity of waste to be generated 12
3.5.1 Waste water generation & utilization 12
3.5.2 Solid waste generation & disposal 13
3.6 Schematic representations of the feasibility drawing which give
information of EIA purpose
13
4.0 Site Analysis 13
4.1 Land Form, Land use and Land ownership. 13
4.2 Existing Infrastructure 14
4.3 Soil classification 14
4.4 Climatic data from secondary sources 14
4.5 Social Infrastructure available 14
5.0 Planning Brief 14
6.0 Proposed Infrastructure 14
6.1 Project Area 14
6.2 Residential Area 14
6.3 Green Belt 14
6.4 Social Infrastructure 15
6.5 Occupation health 15
7.0 Rehabilitation and Resettlement (R & R) Plan 15
8.0 Project Schedule & Cost Estimates 15
9.0 Analysis of proposal (Final Recommendations) 16
2
1.0 Executive Summery
M/s. Vadivarhe Speciality Chemicals Ltd. Proposed is for Bulk Drugs & Drugs Intermediates
manufacturing project at Gut No. – 204, Nashik – Mumbai highway, A/p – Vadivarhe, Tal. –
Igatpuri, Dist. – Nashik – 422 403 (Maharashtra).
Table: Summary of Proposed Plant
Sr.No. Parameter Description
1 Name And Address M/s. Vadivarhe Specialty Chemicals Ltd. (VSCL)
Gut No. – 204, Nashik – Mumbai highway, A/p –
Vadivarhe, Tal. – Igatpuri, Dist. – Nashik – 422 403
Maharashtra
2 Category of Project as per
EIA Notification
5(f) “B”
3 Proposed Project Cost Rs. 22 crore
4 Area of the project Total Area - 12500 Sq. M.
Built-up area: 3908.74 Sq. M
Green Belt area: 4125 Sq. M
Utility block: 363 Sq. M.
Boiler House: 74.12 Sq. M.
5 Latitude & Longitude Latitude: 19°50' 52.79"N
Longitude: 73°40'44.56"E
6 Product Bulk Drugs & Drugs Intermediates
7 Existing Production Capacity
with Consent to Operate
13.3 MT/M
Proposed Production Capacity
With Consent to Establish
9.321 MT/M (8.089+1.142)
Additional new product
Capacity
1152.03MT/M
Total Production 1174.651 MT/M
8 Capacity of Boiler 850 kg
9 Total water Requirement 95.4 m3/day
10 Waste Water Generation 44.41 m3/day
11 Total Power Requirement 150 KVA
12 Total Fuel Requirement 1) LDO - 500 liter/day 2) HSD – 50 Liter/day
13 Manpower Direct employment:
1. Permanent Staff : 70 nos
2. Permanent Workers : 16 nos
Indirect Employment:
1. Contract Workers – 100 nos
3
2.0 Introduction/Brief Project Description
The objective of this pre feasibility study is to provide information for the Bulk Drugs and
Intermediates manufacturing unit by M/s. Vadivarhe Speciality Chemicals Ltd. Gut No. – 204,
Nashik – Mumbai highway, A/p – Vadivarhe, Tal. – Igatpuri, Dist. – Nashik – 422 403
(Maharashtra).
M/s Vadivarhe Speciality Chemicals Ltd. is a reputed name in the Bulk Drugs & Drugs
Intermediates manufacturing. It is a limited organization engaged in manufacturing Bulk Drugs &
Drugs Intermediates manufacturing products.
The M/s. Vadivarhe Speciality Chemicals Ltd. has been incorporated with main object to
manufacture Bulk Drugs & Intermediates which have a good export potential. The ever-
increasing demand for the products in India & Abroad has prompted the promoters to undertake
manufacturing of some selected Bulk Drugs & Intermediates. As per the provision of “EIA
Notification No.S.O.1533 (E)” dated 14.09.2006 as amended on December 01, 2009, the project
comes under “Category A”
2.1 Project Proponent
M/s. Vadivarhe Speciality Chemical Ltd. is incorporated in the year 2007 to manufacture Bulk
Drug & Intermediates Mr. Vasant Jagtap is the managing Director of this Company Having
experience in Bulk Drug manufacturing & R&D for more than 20 years.
2.2 Brief Description of Nature of The Project
The proposed project is to manufacture synthetic organic chemicals (Bulk Drug) of
1174.651MT/M capacity. The pharmaceutical industry includes the manufacture, extraction,
processing, purification & packing of chemical materials to be used as medicines .Pharmaceutical
manufacturing is divided into two major stages the production of active ingredient or
drug(Primary processing or manufacturing & Secondary processing) the conversion of the active
drugs into products suitable for administration.
2.3 Need for The Project & It’s Importance To The Country & Or Region
Mumbai & Surrounding area has emerged as major drug manufacture city with a presence in
global market. Pharma industry in the state contribute more than one third to the country total
production.
Most of the companies have set up their R&D facilities in the state, thus making the state the
pharmaceutical capital of the country .
Mumbai & Surrounding has developed as major production center for bulk drugs due to the
location if the many major pharmaceutical industries such as Lupin ltd, Matrix Labs, Cipla,
Ranbaxy etc. besides a large no. of medium & small industries manufacturing Bulk Drugs of all
kinds.
The Indian Pharmaceutical Industry today is in the front rank of India’s science based industry
with wide ranging capabilities in the complex field of drug manufacture & technology .
4
Bulk drugs have become a part of our life for sustaining many of our day-to day
activities, preventing & controlling diseases. Bulk drug manufacturing sector in
India is well established & has recorded a steady growth in the overall Indian
industrial scenario. The bulk drug & allied industries have been amongst the fatest
growing segments of the Indian Industry.
India’s pharmaceutical industry is the third largest in the world in terms of volume.
Its rank is 14th
in terms of value. India is also one of the top five active
pharmaceutical ingredients (API) producers (with a share of about 6.5%)
The ever-increasing demand for bulk drug & intermediated in India & abroad as
well as changing market condition for manufacture & sale of products has prompted
the promoters to go for manufacturing of Bulk Drug & Intermediates as well as
chemicals.
2.4 Demands-Supply Gap
As per IMS Retail Drug Monitor, sales through pharmacies in thirteen leading markets for the
year to August 2003 are $ 298.7 Billion. According to the IMS World Review, in 2004 global
audited sales of pharmaceuticals rose 8% (at constant dollar rate) to reach US $ 400.6 Billion.
IMS world Review tracks actual sales of approximately 90% of all prescription drugs & certain
over-the-counter (OTC) products in more than 70 countries. Using proprietor data projection
methodologies to estimate total global pharmaceutical sales, which grew to US $ 430.3 Billion in
2005. Despite economic challenges in the world’s leading markets & a lower than normal number
of new products introduction, the global pharmaceutical industry experienced good growth in
2005.
During 2005-06, the state produced bulk drug & formulations worth US $ 2.5 billion. The exports
from the state stood at US $ 1.0 billion in 2004-05 registering an annual growth of more than 20%
the sector accounts for about 20% of the total exports from state
Imports Vs Indigenous Production
The products including third generation antibiotics are high in demand in the export market. Also
their demand is increasing in the domestic market. Production of these drugs domestically reduces
the need to import these in future along with significant scope for export in these products.
Domestic/ Export Markets
In the initial phase the products shall comprise of mainly intermediates which shall be supplied to
domestic API firms. Subsequently when the blocks for APIs will be erected, the APIs will be
supplied to both domestic as well as export market
5
2.5 Employment Generation (Direct & Indirect) Due To The Project
The activities under industry would produce improvement in the socio-economic status of people
in the study area in terms of local labor employment & contract basis jobs. The proposed activity
might provide employment opportunities to the local populace, especially in business & other
services like transportation activity.
It is expected to direct or indirect employ about 50-60 people of various skills will be required
during construction as well as operation phase.
The details of employment shown in below table-
Particulars N0. Of
Employees Functional
Key managerial staff &
Administration
30 Finance, Marketing , Production,
Quality Control, R&D, Logistic Office
work etc
Skilled & semiskilled 60 Production process , Maintenance
stores, Safety & un Skilled workers.
Total 90
3.0 Project Description
M/s. Vadivarhe Speciality Chemicals Ltd. manufacturing unit at Gut No.204, Nashik-Mumbai
highway, A/P-Vadivarhe, Tal-Igatpuri, Dist-Nashik-422403 (Maharashtra) Location map is
shown at Figure.
Latitude: 19°50' 52.79"N
Longitude: 73°40'44.56"E
There are no archaeological, historical sites located near project site. Therefore, the project site
does not offer any negative impact on the local area. But rather have a positive impact on socio
economic conditions of the habitants around it.
The plant is well connected with National Highway No.3 (NH3) at 0.5 KM from Site & Railway
line at Igatpuri Railway station at 20.87 km & Nashik Railway station at 20.25 km. The total of
about 12500 Sq. Mt. of land is acquired for this project.
7
3.1 The List Product & Production capacity is given below.
Sr. No. A) List of Existing Product with Consent to Operate
Annual Production
Quantity MT/Month
1 Trimethyl Ortho Proplonate (MOP) 0.25
2 Tributly Ortho Proplonate (BOP) 0.1
3 Trimetthyl Ortho Valerate (MOV) 0.2
4 Tributyl Ortho Valerate (BOV) 0.25
5 Trimethyl Ortho Butyrate (MOBu) 0.05
6 Trimethyl Ortho Benzoate (MOB) 0.05
7 4- Aminomorpholine (4AM) 0.4
8 Ethyl-N-dodecanoyl-L-Arginate Hydrochloride 0.5
9 Ethyl Atropate (EA) 0.5
10 3-Aminophthalhydrazide (3APH) 0.2
11 3-Aminophthalhydrazide Sodium Salt 0.05
12 1-Bromo 4 Tert Butyl Benzene 0.5
13 N-N Dimethyl Formamide Dimethyl Acetal (DMFDMA) 0.2
14 Tert-Butoxy bis (dimethyl amino) methane 0.2
15 Brji (wax) 3.0
16 Hydol (wax) 3.0
17 Stereoamido propyl dimethyl amine (wax) (SAPDMA) 3.0
18 Sodium Thioglycolate (NaTG) 0.1
19 Calcium Thioglycolate (CaTG) 0.1
20 Miscellaneous Chemicals in R&D lab 0.2
By-Product
1 Hydrobromic acid (30%solution) 0.19
2 Ammonium Chloride 0.25
B) List of Product with Consent to Establish for Expansion -1
21 Adapalene 0.005
22 Atorvastatin 0.008
23 Brimonidine 0.005
24 Bromfenac 0.002
25 Deslortadine 0.025
26 Escitalopram Oxalate 0.1
27 Febuxostat 0.04
28 Gabapentin 0.1
29 Glimepride 0.12
30 Montelukast Na 0.1
31 Moxifloxacin 0.7
32 Nitazpxanide 0.5
33 Olopatadine 0.002
34 Olanzapine 0.1
35 Olmesartan 0.025
8
36 Prasugrel 0.03
37 Risperidone 0.025
38 Rosuvastatin calcium 0.1
39 Strontium 0.15
40 Tazarotene 0.002
41 Telmisartan 0.3
42 Trospium 0.05
43 Ezetimibe 0.04
44 Citalopram Hydrobromide 0.05
45 Phenylephrine Hydrochloride 5
46 Niacinamide 0.01
47 Fructopyranose Sulfamate/ Topiramate 0.5
C) List of Product with Consent to Establish for Expansion-2
48 Losartan Potassium 0.1
49 Irbesartan 0.05
50 Valsartan 0.02
51 Telmisartan 0.02
52 Olmesartan Medoxomil 0.02
53 Carvedilol 0.1
54 Sotalol Hydrochloride 0.025
55 Fluticasone Propionate 0.001
56 Salmeterol xinafoate 0.002
57 Formeterol Fumarate 0.002
58 Montelucast Sodium 0.02
59 Pranlucast Hydrate 0.02
60 Methdilazine Hydrochloride 0.05
61 Lamotrizine 0.05
62 Pregabalin 0.1
63 Brimonidine Tartarate 0.002
64 Dorzolamide Hydrochloride 0.02
65 Betmethasone Dipropionate 0.02
66 Betmethasone Valerate 0.02
67 Ambroxol Hydrochloride 0.5
D. List of New Product-
68 Quinoline-6 carboxylic acid 1
69 Di methyl malonic acid (New Addition ) 0.1
70 4-chloro-3-nitroanisole 1
71 Sodium hippurate hydrate 1
72 4-Morpholinoaniline 0.1
73 N-Benzylglycine ethyl ester 0.5
74 6-Methoxyquinoline 0.1
75 1-Bromo2-Methyl propane 0.5
76 Indole-3-methanol(Indole-3-cabinol) 0.1
77 Indole-3-carboxylic acid 0.1
9
78 Indole-5-carboxylic acid 0.1
79 3-(Dimethylaminomethyl)Indole (Gramine) 0.01
80 Trimethyl Orthoacetate 0.5
81 Cheamide 5
82 L-Cystine disodium Salt 0.1
83 Methdilazine hydrochloride 0.5
84 Indole-3-carboxaldehyde (Indole-3-aldehyde) 0.1
85 3-Cynoindole 0.1
86
Tert-Butoxy-bis(dimethyl amino) mehane (Brederk”s
reagent)
2.4
87 Propionyl chloride 0.5
88 3-Aminophthalhydrazide sodium salt 0.6
89 Phenyl phosphate disodium salt 0.1
90 Aloe Vera Juice (Stabilised) 1000
91 Lecithin powder 0.1
92 Ammonium thioglycolate (Solution) 1
93 5-Bromo,5-Nitro,1:3Dioxane 0.5
94 Phenylepherin Hydrochloride (PPH) 0.5
95 Heck Coupled Product 0.1
96 Chloro Atavaquinone 0.1
97 Immidazolyl acetic acid 0.1
98 Montelukast sodium 0.6
99 Moxifloxacin hydrochloride 24
100 Topiramate 3
101 Risperidone 0.6
102 Olopatadine hydrochloride 0.005
103 Escitalopram oxalate 1.2
104 Brimonidine tartrate 0.018
105 Strontium ranelate 1.2
106 Desloratidine 2.4
107 Olmesartan Medoxomil 0.1
108 Nitazoxanide 0.5
109 Atorvastatin calcium 24
110 Bromfenac sodium 0.018
111 Febuxostat 3
112 Prasugrel hydrochloride 0.2
113 Alcaftadine 0.004
114 Cinacalcet hydrochloride 0.1
115 Dapoxetine hydrochloride 0.3
116 Desloratidine 24
117 Dimethyl Fumarate 0.12
118 Losartan Potassium 18
119 Nitazoxanide 3
120 Pitvastatin Calcium 0.06
10
121 Flavoxate hydrochloride 0.06
122 Flovoxamine Maleate 0.06
123 Timolol maleate 0.06
124 Ketoprofen 5
125 Clopidogrel Bisulfate 5
126 Tetrabenazine 0.2
127 Agomelatine 0.2
128 Rupatadine Fumarate 1.2
129 Lymecycline 2.4
130 Dexketoprofen trometamol 12
131 Trospium chloride 0.1
132 Almotriptan maleate 0.005
133 Dronedarone hydrochloride 1
134 Lurasidone hydrochloride 0.01
135 Milrinone 0.002
136 Pramipexole dihydrochloride 0.006
137 Pregabalin 1.2
138 Teriflunamide 0.06
139 Roflumilast 0.002
140 Solefenacin 0.003
141 Tolperisone hydrochloride 0.1
Total Production Capacity- 1174.524MT/M
3.2 Raw material requirement
All the raw materials required for manufacturing of above products will be sourced from local
market- List is attached
3.3 Manufacturing Process: The manufacturing process of bulk drug consist of chemical
synthesis extending to stages of processing involving different type of chemical reaction. The
generalized flow chart for bulk drug manufacturing is shown in Flow chart
Generalized flow chart for Bulk Drug Manufacturing-
11
3.4 Resource – Utilize & Recycling
3.4.1-Water Requirement
Water requirement of the project for domestic & Industrial activity during operation phase is 94.4
m3/day The water requirement sourced from Bore well The detailed water requirement shown in
below Table
Table water Requirement details
Purpose Water Consumption Losses Effluent
Exist
Water
Cons.
(m3/d)
Prop.
Water
Cons.
(m3/d)
Total
Water
Cons.
(m3/d)
Loss
Exist.
Water
(m3/d)
Prop.
Water
(m3/d)
Total
Loss
(m3/d)
Effluent
Exist.
(m3/d)
Effluent
Prop.
(m3/d)
Total
Effluent
after
Expansion
(m3/d)
Industrial
processing
6.41 49.0 55.41 0.20 15.0 15.20 6.21 34.0 40.21
Industrial
cooling and
Boiler
18.0 5.0 23 18.0 5.0 23.0 Nil Nil Nil
Domestic 2.0 3.0 5 0.2 0.6 0.8 1.8 2.4 4.2
Gardening 11.99 Nil 11.99 11.99 Nil 11.99 Nil Nil Nil
Total 38.4 57 95.4 30.39 20.6 50.99 8.01 36.4 44.41
12
The total water requirement after expansion will be 95.4 M3/day. The water requirement is
fulfilled from Own Bore well and tanker.
3.3.2 Power Requirement
The power requirement after expansion will be around 150 Kw. The source of power is MSEB
and DG Sets. The DG Set having 250 KVA capacities for power failure.
3.4.3 Fuel Requirement
Total LDO Requirement is around 500 lit/day and HSD 50 Lit/day
3.5 Quantity of wastes to be generated
3.5.1 Waste Water Generation and utilization
Total effluent generated in the project is 44.41 KLD. The treated water will be reused for plant
operations.
Waste Water Treatment
Effluent generated from the project will be treated through effluent treatment plant. Existing ETP
having Capacity 50 CMD. ETP flow chart attached
ETP Flow Chart
Air Blower
Process
Effluent
Domestic
effluent
Oil & grease trap
Eqn/Neutn tank -2 no
Anaerobic digester
SAFF
Bioreactor Sec clarifier tank
Filter press
Sand filter & Carbon filter
Treated Water Effluent pump
Treated Water Tank
Clar water tank
Primary Parallel plate settler tank
Filter Cake
Filtrate
Title : Flow Diagram of E.T.P.
Client : Vadivharhe Specialty Chemicals Ltd,Nasik
By Universal Associates
13
3.5.2 Solid waste generation & disposal
The types of Hazardous and non Hazardous wastes generated from the project, method of disposal
is shown in below table
The Solid waste will be classified into hazardous waste and other waste which is being handled
under the agency of Pollution Control Board. The industry entered into an agreement with
Common hazardous waste treatment and disposal facility (CHWTSDF) where the waste is
characterized and scientifically disposed off in a secured Landfill after Stabilization to prevent
any sought of impact on environment
Table: Hazardous Waste Quantity
Sr. No. Cat. Name of
Hazardous Waste
Existing
Qty
Proposed Total Disposal
1 20.3 Distillation
Residues
2.5 Kg/day Nil 2.5
Kg/Day
CHWTSDF
2 28.1 Waste Residue Nil CHWTSDF
3 28.5 Spent Solvent Nil CHWTSDF
4 34.3 ETP Sludge 0.8
MT/Year
6.2
MT/Month
7
MT/Month
CHWTSDF
5 35.1 Filter Cloth 5
Kg/Month
Nil 5 Month CHWTSDF
3.6 Schematic representations of the feasibility drawing which give information of EIA
purpose.
The applicability of the S.O. 1533 for the proposed project was explored by considering different
possibilities & provision made in the said Notification. Considering the products & project
location of the proposed project it is noiticed that the proposed project falls under category 5 (F)
“A” of the Schedule – I of EIA Notification SO 1533.
4.0 Site Analysis
M/s. Vadivarhe Speciality Chemicals Ltd. is located at Gut No. – 204, Nashik – Mumbai
highway, A/p – Vadivarhe, Tal. – Igatpuri, Dist. – Nashik – 422 403 (Maharashtra).
The nearest habitation from the site is Vadivarhe (Village) at a distance of 1.2 KM.
The nearest railway station is Igatpuri at a distance of 20.87 KMs from the site.
The nearest airport is Nashik Air port at a distance of 40 KMs
The Nearest road ways National (NH – 3)
4.1 Land Form, Land use and Land ownership.
The proposed land for setting bulk drug unit in Notified Industrial Estate of 12500.00 SQ. M. The
land is acquired by M/s. Vadivarhe Speciality Chemicals Ltd. for establishing their
Manufacturing Facility
14
4.2 Existing Infrastructure.
There is well established existing Infrastructure at proposed Site because it is located in
Vadivarhe Village
4.3 Soil classification
The district is mainly covered by three types of soils Viz. red sandy soil (Dubbas and Chalkas)
Red earth (with loamy sub-soils and Chalkas) and black cotton soils. Red andy soils and red earth
are permeable and well drained.
4.4 Climatic data from secondary sources
Temperature Maximum: 35.9 °C
Minimum: 12.5 °C
Normal annual rainfall 814 mm
4.5 Social Infrastructure available
The social infrastructure facilities are available near to proposed site.
5.0 Planning Brief
Proposed plant activities will be started after getting statutory clearance form related authorities.
The project will be completed within two years.
Further proposed project activities will take care of all the rules and regulation of statutory
authority and provide the control measure and devices to achieve the standard norms
6.0 Proposed Infrastructure
6.1 Project Area
Basic infrastructure to be developed along with civil construction and installation of required
plant and machineries.
6.2 Residential Area
No residential area is involved in the proposed project. The employees are accommodated in
nearby Residential areas
6.3 Green Belt
The unit has already developed green belt area @ 3500 sq. m within and on the surrounding of the
existing premises and will also increase the green belt @ 625 sq. m (Total after expansion 4125
15
sq. m) which will not only improve the soil conditioning but will also prevent soil erosion and the
landscape & give slight beneficial impact on the land usage.
6.4 Social Infrastructure
The Vadivarhe Specialty Chemicals Ltd. project has generated a fair amount of direct and indirect
employment in the study region. The local economy has received a boost due to employee
spending and services generated by Vadivarhe Specialty Chemicals Ltd. Migration into the
existing area or displacement of existing population is insignificant. Housing, transport, water,
power supply, medical, educational and other civic amenities are not adversely affected nor
appear to get affected in future.
6.5 Occupation health
Various precautions have been taken by the unit to reduce health hazardous and medical check-up
is also carried out regularly to avoid occupational hazard.
Drinking water supply for the employees is provided by the project proponent and the
standard of the drinking water is as per WHO guidelines.
Proper sanitary facilities are made available by the project proponent so that employees do
not suffer from any health ailments.
Training includes information on accident prevention, proper control and maintenance of
equipment and safe material handling practices.
MSDS of the chemical used are made available at the place of use.
Storage and process areas are posted with “No Smoking” signs. Smoking is prohibited
throughout the factory. All management staff, Executives on their rounds to factory
ensures the compliance.
Pre-employment medical check-up at the time of employment.
The unit has appointed the medical officer cum industrial hygienist for the regular medical
examination and treatment of the employee.
Certificate of fitness of employ is maintained.
Equipment required for personal safety like water jet blankets, gloves, helmets, safety
belts, first aid boxes etc. are provided.
7.0 Rehabilitation and Resettlement (R & R) Plan
Rehabilitation & Resettlement (R&R) plan is not applicable to proposed project it is proposed is
located at existing premise
8.0 Project Schedule & Cost Estimates
Proposed project activities will be started after getting statutory clearance form related authorities.
The project will be completed within two years
16
Sr. No. Particulars Amount Rs in lakhs
1 Land 44,72,000.00
2 Factory Building 6,41,81,068.00
3 Plant & Machinery &
Equipments
9,33,11,969.00
4 Furniture & Fixture 22,05,789.00
5 Other Movable/ Immovable
Fixed assets
4,58,49,088.00
Total 21,00,19,914.00
Cost of environmental protection measures (Rs. Lakhs)
No. ITEM Capital Cost
(Rs, Lacs)
Recurring Cost per
annum (Lacs)
1 Air Pollution Control 20 5
2 Water Pollution Control 75 10
3 Noise Pollution Control 5 1
4 Environment Monitoring and Management 10 2
5 Rain Water Harvesting 15 1
6 Occupational Health 10 2
7 Green Belt 5 2
8 Safety management. 5 2
9 Laboratory and chemicals 10 3
10 Operation & Maintenance of ETP - 12
Total 170 35
9.0 Analysis of proposal (Final Recommendations)
Proposed expansion activity will provide benefits to the local people in terms of financial and
social welfare.
Local people will get direct financial benefit by way of employment.
Local people will get some contracts of supply and services to get indirect income.
Company will contribute in improving education and health facilities in nearby area.
Recommended